New hope for dialysis patients: drug targets debilitating itch
NCT ID NCT07526324
First seen Apr 15, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests whether the drug difelikefalin can reduce severe itching in people with advanced kidney disease who are on dialysis. About 106 adults will receive either the drug or a placebo during their dialysis sessions for 6 weeks. The main goal is to see if itching scores improve, and the study will also check if quality of life gets better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ITCHING SYMPTOMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.